Set a repeating alarm on your phone or an event in your calendar with a clear label, like "tirzepatide injection time." Pair it with a habit: Tie your injection to a repeated weekly event, like Sunday meal prep or checking your calendar on Monday morning
Using medical-grade peptides that work at the cellular level, this treatment helps restore balance, boost energy, and promote natural healing throughout the body
Serious Adverse Events Serious adverse events were relatively uncommon and did not show a clear dose-response signal
Discontinuation and Duration Dependent Cardiovascular Risk Compared with continual use of GLP-1s, discontinuing treatment for 6 months was associated with a 4% increased risk of major adverse cardiovascular events
Tirzepatide is given as a once-weekly subcutaneous injection, starting at 2.5 mg and increasing to 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg over time based on tolerability and glycemic response